Quarterly Transactions Made in Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS). The information is specifically focused on institutions that hold shares of Keros Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2022 | 1,247,704 | 988,026 | 2,235,730 | 1,142,807 | 0 | 1,142,807 | 1,092,923 | |
| Q4 2022 | 2,270,465 | 1,216,502 | 3,486,967 | 1,006,942 | 0 | 1,006,942 | 2,480,025 | |
| Q1 2023 | 1,934,014 | 2,162,777 | 4,096,791 | 1,817,667 | 1,330 | 1,818,997 | 2,277,794 | |
| Q2 2023 | 1,729,218 | 1,328,155 | 3,057,373 | 1,194,240 | 0 | 1,194,240 | 1,863,133 | |
| Q3 2023 | 1,981,110 | 122,933 | 2,104,043 | 1,363,895 | 0 | 1,363,895 | 740,148 | |
| Q4 2023 | 4,200,463 | 2,635,702 | 6,836,165 | 1,356,505 | 0 | 1,356,505 | 5,479,660 | |
| Q1 2024 | 5,290,005 | 3,866,801 | 9,156,806 | 4,165,634 | 200 | 4,165,834 | 4,990,972 | |
| Q2 2024 | 3,006,675 | 335,935 | 3,342,610 | 3,213,669 | 0 | 3,213,669 | 128,941 | |
| Q3 2024 | 4,038,410 | 1,677,773 | 5,716,183 | 1,793,552 | 0 | 1,793,552 | 3,922,631 | |
| Q4 2024 | 6,380,020 | 2,509,026 | 8,889,046 | 4,708,220 | 26,237 | 4,734,457 | 4,154,589 | |
| Q1 2025 | 9,790,306 | 10,346,083 | 20,136,389 | 9,263,818 | 550,000 | 9,813,818 | 10,322,571 | |
| Q2 2025 | 7,389,293 | 4,969,038 | 12,358,331 | 6,934,235 | 0 | 6,934,235 | 5,424,096 | |
| Q3 2025 | 3,087,902 | 588,681 | 3,676,583 | 5,634,752 | 0 | 5,634,752 | -1,958,169 | |